References:
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology
of 2019 novel coronavirus: implications for virus origins and receptor
binding. Lancet. 395: 565-574, 2020.
- Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm
syndromes and immunosuppression. Lancet 395: 1033-1034, 2020.
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular
Considerations for Patients, Health Care Workers, and Health Systems
During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll
Cardiol 2020 Mar 18. doi: 10.1016/j.jacc.2020.03.031
- Darlenski R, Tsankov N. COVID-19 pandemic and the skin: what should
dermatologists know? Clin Dermatol 2020 Mar 24.
https://doi.org/10.1016/j.clindermatol.2020.03.012
- Weinkove R, McQuilten ZK, Adler J et al. Managing haematology and
oncology patients during the COVID-19 pandemic: interim consensus
guidance. Med J Aust 2020 May 13. doi: 10.5694/mja2.50607
- Amanda C. Guidon, Anthony A. Amato. COVID-19 and neuromuscular
disorders. Neurology 2020 Apr 13. doi:10.1212/WNL.0000000000009566
- Liang W, Guan W, Chen R et al. Cancer patients in SARS-CoV-2
infection: a nationwide analysis in China. Lancet Oncol 21: 335–7,
2020.
- Yu J, Ouyang W, Chua MLK et al. SARS-CoV-2 transmission in patients
with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol
6(7): 1108-1110, 2020.
- James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment
strategies, and hematology consultation in massive postpartum
hemorrhage: results of a quantitative survey of
obstetrician-gynecologists. Int J Womens Health 4(7): 873-881, 2015.
- Fox
TA, Troy-Barnes
E, Kirkwood
AA et al. Clinical outcomes and risk factors for severe COVID-19
infection in patients with haematological disorders receiving chemo-
or immunotherapy. Br J Haematol 2020 Jul 17. doi: 10.1111/bjh.17027
- He W, Chen L, Chen L et al. COVID-19 in persons with haematological
cancers. Leukemia 34: 1637-1645, 2020.
- Parnas M, Sheiner E, Shoham-Vardi I et al. Moderate to severe
thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol
128(1-2):163-168, 2006.
- Ten Berg MJ, van den Bemt PM, Shantakumar S et al. Thrombocytopenia in
adult cancer patients receiving cytotoxic chemotherapy: results from a
retrospective hospital-based cohort study. Drug Saf 34: 1151–1160,
2011.
- Huang C, Wang Y, Li X et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506,
2020.
- Fan BE, Chong VCL, Chan SSW et al. Hematologic parameters in patients
with COVID‐19 infection. Am J Hematol 2020 Mar 04.
doi:https://doi.org/10.1002/ajh.25774.
- Terpos
E, Ntanasis-Stathopoulos L,
Elalamy
I et al. Hematological findings and complications of COVID-19. Am J
Hematol 95: 834–847, 2020.
- Zhou F, Yu T, Du R et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet 395: 1054–1062, 2020.
- Han H, Yang L, Liu R et al. Prominent changes in blood coagulation of
patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020 Jun 25.
doi:https://doi.org/10.1515/cclm-2020-0188.